Key result
Digoxin shows no link to prostate cancer mortality but is linked to higher all-cause mortality.
Cohort (n=5,732)
Answers are grounded in this paper and cite their sources.
OBJECTIVE: To examine the association between digoxin exposure and mortality in men with prostate cancer using linked Irish National Cancer Registry and pharmacy claims data. PATIENTS AND METHODS: Prostate cancer cases were identified from the database and digoxin exposure at prostate cancer diagnosis was identified from prescription claims. Digoxin users were matched to non-users using a propensity score to identify men with similar cardiovascular comorbidity. Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated for the association between digoxin exposure and all-cause and prostate cancer-specific mortality (PCSM). Analyses were repeated in the propensity score-matched cohort. Effect modification of treatment with radiation or androgen-deprivation therapy by digoxin exposure was also assessed. RESULTS: In all, 5732 men with a prostate cancer diagnosis (2001-2006) were identified (digoxin exposed, 391). The median follow-up was 4.3 years. Digoxin exposure was associated with a small non-significant increase in PCSM in the full cohort (HR 1.13, 95% CI 0.91, 1.42) and the propensity. score-matched cohort (HR 1.17, 95% CI 0.88, 1.57). Adjusted HRs for all-cause mortality were increased for digoxin exposed men (HR 1.24, 95% CI 1.07, 1.43). Interactions with treatments received were not significant. CONCLUSIONS: These results suggest digoxin exposure is not associated with reduced PCSM. Further investigation of other cardiac glycosides that have shown anti-cancer potential may be warranted.
No takes yet. Share an insight, caveat, or question.
Flahavan et al. (2013) conducted a cohort in Prostate cancer (n=5,732). Digoxin exposure vs. Digoxin non-users was evaluated on Prostate cancer-specific mortality (PCSM) (HR 1.13, 95% CI 0.91-1.42). Digoxin exposure was not associated with prostate cancer-specific mortality but increased all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: